Radio wave electrotherapy with a radiofrequency of 448 khz for the treatment of patients with organic erectile dysfunction: a prospective, randomized, blind, Sham-controlled, parallel-group study


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Aim. To evaluate the efficiency of radio wave electrotherapy (448 kHz) for the treatment of patients with organic erectile dysfunction (ED). Materials and methods. A prospective, randomized, blind, sham-controlled clinical trial was carried out. Inclusion criteria were as following: 1) patients with 5 to 20 points on the IIEF-5 score; 2) patients with proven organic erectile dysfunction lasting at least 6 months; 3) patients with penile arterial insufficiency and/or venous insufficiency, confirmed by doppler study of penile vessels with pharmacological stimulation (peak systolic velocity (PSV) <25 cm/s, end-diastolic blood flow velocity (DPV) >5 cm/s, resistance index (IR) < 0.8). The participants were randomized into two groups (experimental and control) in a 1:1 ratio. The full treatment course lasted 9 weeks. Patients underwent an assessment of erectile function based on questionnaires (IIEF-5, SEP, Schramek), as well as Doppler ultrasound of the cavernous arteries before inclusion in the study as well as a after treatment. Results. The study included 61 men (experimental group [n=31], control group [n=30]. There was a significant difference in the IIEF-5 scores after treatment between the experimental group and the control group (19.5±3.2 vs. 15.1±5.4, p=0.017, respectively). Significant differences were also noted in mean total score of the SEP questionnaire: an increase to 3.6±1.0 in the treatment group compared to 2.4±1.1 in the control group (p=0.004). The results of the Schramek questionnaire also demonstrated a significant increase in the mean score in the experimental group compared to the control group: 4.2±0.6 vs. 3.2±1.0 (p=0.011). The response time to the drug and the detumescence time also significantly differed between the two groups: 11.9±4.0 min vs. 15.5±4.1 min, p=0.001 and 126.6±60.7 min vs. 66.2±40.9, p<0.001, respectively. Neither complications nor any adverse events were recorded during treatment or after its completion. Conclusions. Radio wave electrotherapy with a radiofrequency of448 kHz can improve the IIEF-5, SEP and Schramek scores, as well as the indicators of ultrasound Doppler ultrasonography in patients with organic ED. To assess the feasibility of this method in patients with organic ED of different stages, further studies are needed.

Толық мәтін

Рұқсат жабық

Авторлар туралы

L. Chuvalov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: chuvalovleo386@mail.ru
urologist, PhD student, Institute for Urology and Reproductive Health

D. Korolev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: korolevdmitryo@gmail.com
Candidate of Medical Sciences, Senior Researcher, Institute for Urology and Reproductive Health

C. Azilgareeva

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: camilla.azilgareeva@yandex.ru
student, International School «Medicine of the Future»

M. Taratkin

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: marktaratkin@gmail.com
urologist, researcher, Institute for Urology and Reproductive Health

Y. Olefir

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: olefir_yu_v@staff.sechenov.ru
Doctor of Medical Sciences, Professor, Institute for Urology and Reproductive Health

D. Fiev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: fiev@mail.ru
Urologist, Doctor of Medical Sciences, Institute for Urology and Reproductive Health

I. Lumpov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: urology27@mail.ru
urologist, Institute for Urology and Reproductive Health

Y. Gorobets

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: gorobets9@yandex.ru
resident, Institute for Urology and Reproductive Health

D. Enikeev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: enikmic@mail.ru
Doctor of Medical Sciences, Professor, Head of the International Department, Institute for Urology and Reproductive Health

L. Rapoport

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: leonidrapoport@yandex.ru
Doctor of Medical Sciences, Professor, Deputy Director, Institute for Urology and Reproductive Health

M. Enikeev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: enikmic@mail.ru
Doctor of Medical Sciences, Professor, Head of the Urological Department №2, Institute for Urology and Reproductive Health

Әдебиет тізімі

  1. Marumo K., Murai M. Aging and erectile dysfunction: The role of ageing and concomitant chronic illness.Int J Urol. 2001;8(8):S50-557.
  2. Shamloul R., Ghanem H. Erectile dysfunction. The Lancet. 2013;381:153-165.
  3. Cao S., Yin X., Wang Y, Zhou H., Song F, Lu Z. Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-Analysis. PLoS One. 2013;8(4).
  4. Calogero A.E., Burgio G., Condorelli R.A., Cannarella R., La Vignera S. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male. 2019;22:12-19.
  5. Salonia A., Bettocchi C., Boeri L., Capogrosso P., Carvalho J., Cilesiz N.C., et al. European Association of Urology Guidelines on Sexual and Reproductive Health-2021 Update: Male Sexual Dysfunction [Internet]. European Urology. Elsevier; 2021;80:333-357. [cited 2021 Nov 17]. Available from: http://www.europeanurology.com/article/S0302283821018133/fulltext
  6. Ventimiglia E., Capogrosso P., Montorsi F., Salonia A. The safety of phosphodiesterase type 5 inhibitors for erectile dysfunction. Expert Opinion on Drug Safety. 2016;15:141-152.
  7. Michl U., Molfenter F., Graefen M., Tennstedt P., Ahyai S., Beyer B., et al. Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy. J Urol. 2015;193(2):479-483.
  8. Li W.Q., Qureshi A.A., Robinson K.C., Han J. Sildenafil use and increased risk of incident melanoma in US men: A prospective cohort study. JAMA Intern Med. 2014;174(6):964-970.
  9. Salonia A., Bettocchi C., Carvalho J., Corona G., Jones T.H., Kadioglu A., et al. Sexual and Reproductive Health EAU Guidelines [Internet]. 2021. 282 p. Available from: https://uroweb.org/guideline/sexual-and-reproductive-health/#10
  10. Kumaran B., Watson T. Skin thermophysiological effects of 448 kHz capacitive resistive monopolar radiofrequency in healthy adults: A randomised crossover study and comparison with pulsed shortwave therapy. Electromagn Biol Med. 2018;37(1):1-12.
  11. Hernandez-Bule M.L., Marti'nez-Botas J., Trillo M.A., Pai'no C.L., Ubeda A. Antiadipogenic effects of subthermal electric stimulation at 448 kHz on differentiating human mesenchymal stem cells. Mol Med Rep. 2016;13(5):3895-903.
  12. Heinonen I., Bucci M., Kemppainen J., Knuuti J., Nuutila P., Boushel R., et al. Regulation of subcutaneous adipose tissue blood flow during exercise in humans. J Appl Physiol. 2012;112(6):1059-1063.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bionika Media, 2022

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>